MeiraGTx Holdings plc - Ordinary Shares (MGTX): Price and Financial Metrics
MGTX Price/Volume Stats
| Current price | $6.26 | 52-week high | $7.37 |
| Prev. close | $5.93 | 52-week low | $3.85 |
| Day low | $6.07 | Volume | 445,600 |
| Day high | $6.65 | Avg. volume | 320,709 |
| 50-day MA | $6.26 | Dividend yield | N/A |
| 200-day MA | $5.13 | Market Cap | 489.24M |
MGTX Stock Price Chart Interactive Chart >
MeiraGTx Holdings plc - Ordinary Shares (MGTX) Company Bio
MeiraGTx Limited develops gene therapies for acquired and inherited disorders. It offers products for neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS); ocular diseases, including rare inherited blindness and age-related macular degeneration (AMD); and xerostomia, a frequent and debilitating side effect of radiation treatment used in head and neck cancers. The company was founded in 2015 and is based in London, United Kingdom.
MGTX Price Returns
| 1-mo | 1.79% |
| 3-mo | 4.68% |
| 6-mo | 37.28% |
| 1-year | 2.29% |
| 3-year | -59.46% |
| 5-year | -67.56% |
| YTD | 2.79% |
| 2024 | -13.25% |
| 2023 | 7.67% |
| 2022 | -72.54% |
| 2021 | 56.80% |
| 2020 | -24.38% |
Loading social stream, please wait...